PERSONALIS INC (PSNL)
US71535D1063 - Common Stock
Overall PSNL gets a fundamental rating of 2 out of 10. We evaluated PSNL against 59 industry peers in the Life Sciences Tools & Services industry. PSNL has a bad profitability rating. Also its financial health evaluation is rather negative. PSNL is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year PSNL has reported negative net income.
In the past year PSNL has reported a negative cash flow from operations.
In the past 5 years PSNL always reported negative net income.
In the past 5 years PSNL always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of PSNL (-48.11%) is worse than 89.83% of its industry peers.
With a Return On Equity value of -83.67%, PSNL is not doing good in the industry: 81.36% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.11% | ||
| ROE | -83.67% | ||
| ROIC | N/A |
ROA(3y)-34.43%
ROA(5y)-27.22%
ROE(3y)-52.21%
ROE(5y)-40.27%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 24.77%, PSNL is doing worse than 86.44% of the companies in the same industry.
PSNL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for PSNL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.77% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.04%
GM growth 5Y-4.55%
2. Health
2.1 Basic Checks
PSNL does not have a ROIC to compare to the WACC, probably because it is not profitable.
PSNL has more shares outstanding than it did 1 year ago.
PSNL has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, PSNL has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -3.09, we must say that PSNL is in the distress zone and has some risk of bankruptcy.
PSNL has a worse Altman-Z score (-3.09) than 88.14% of its industry peers.
PSNL has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PSNL (0.01) is better than 71.19% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -3.09 |
ROIC/WACCN/A
WACC12.03%
2.3 Liquidity
A Current Ratio of 3.11 indicates that PSNL has no problem at all paying its short term obligations.
PSNL has a Current ratio (3.11) which is comparable to the rest of the industry.
A Quick Ratio of 2.88 indicates that PSNL has no problem at all paying its short term obligations.
PSNL has a Quick ratio of 2.88. This is comparable to the rest of the industry: PSNL outperforms 57.63% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.11 | ||
| Quick Ratio | 2.88 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 14.11% over the past year.
The Revenue has grown by 12.97% in the past year. This is quite good.
PSNL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.24% yearly.
EPS 1Y (TTM)14.11%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q19.4%
Revenue 1Y (TTM)12.97%
Revenue growth 3Y-2.24%
Revenue growth 5Y14.24%
Revenue growth Q2Q17.67%
3.2 Future
Based on estimates for the next years, PSNL will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.55% on average per year.
Based on estimates for the next years, PSNL will show a very strong growth in Revenue. The Revenue will grow by 36.80% on average per year.
EPS Next Y24.31%
EPS Next 2Y16.28%
EPS Next 3Y15.31%
EPS Next 5Y17.55%
Revenue Next Year0.95%
Revenue Next 2Y8.16%
Revenue Next 3Y16.24%
Revenue Next 5Y36.8%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for PSNL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSNL. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PSNL's earnings are expected to grow with 15.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.28%
EPS Next 3Y15.31%
5. Dividend
5.1 Amount
PSNL does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
PERSONALIS INC
NASDAQ:PSNL (4/19/2024, 10:53:39 AM)
1.28
+0.07 (+5.79%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap64.64M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -48.11% | ||
| ROE | -83.67% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 24.77% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.33
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 3.11 | ||
| Quick Ratio | 2.88 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)14.11%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y24.31%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)12.97%
Revenue growth 3Y-2.24%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y